Macquarie Group
DPLO

Macquarie Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Macquarie Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,500
Closed -$30K – 2326
2018
Q1 		$30K Sell
1,500
-14,200
-90% -$331K ﹤0.01% 2048
2017
Q4 		$315K Buy
+15,700
New +$309K ﹤0.01% 1590

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group's DPLO Position: Q2 2018 in Review

Macquarie Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 1,500 shares — an estimated $30K sold.

Macquarie Group first reported a position in DPLO in Q4 2017 and held it in 2 quarters. The position peaked at $315K in Q4 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Macquarie Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • Macquarie Group sold 1,500 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $30K.
  • Macquarie Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 2 quarters.
  • Macquarie Group's DIPLOMAT PHARMACY, INC. position peaked at $315K in Q4 2017.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Macquarie Group's 13F filing for Q2 2018, filed 14 Aug 2018.